Bhalchandra Mirlekar

Author

University of North Carolina at Chapel Hill ORCID

Also Known As

B Mirlekar, Bhalchandra Mirlekar, Chattopadhyay, Samit, De Buysscher T, Michaud, Daniel, Mirlekar, Bhalchandra, Pylayeva-Gupta, Yuliya, Yang N

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Pittsburgh

About

Bhalchandra Mirlekar is an author at University of North Carolina at Chapel Hill specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	834
2	Immunology	4	4	834
3	Cell Biology	3	3	357
4	Autoimmunity	2	2	344
5	Pathology	1	1	13

Bhalchandra Mirlekar

Publications

Citations

H-Index

Page 1

	Year	Citations
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells Hongwei Du, Koichi Hirabayashi, Sarah Ahn, Cancer Cell Cancer ImmunosurveillanceSolid TumorsMedicineImmunologyImmune Checkpoint Inhibitor	2019	477
STING-induced regulatory B cells compromise NK function in cancer immunity Sirui Li, Bhalchandra Mirlekar, Brandon M. Johnson, Nature Cancer ImmunosurveillanceCancer ImmunityImmunologyTumor ImmunityImmunologic Mechanism	2022	282
B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer Bhalchandra Mirlekar, Daniel Michaud, Samuel Lee, Cancer Immunology Research	2020	104
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity Bhalchandra Mirlekar, Yan Wang, Sirui Li, Cell Reports Medicine ImmunologyImmune RegulationPlasma Cell ResponsesImmunologic MechanismImmunoregulatory B Cells	2022	62
IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer Bhalchandra Mirlekar, Daniel Michaud, Ryan Searcy, Cancer Immunology Research	2018	59
B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer Daniel Michaud, Bhalchandra Mirlekar, Colleen R. Steward, Frontiers in Immunology	2022	26
Nuclear matrix protein SMAR1 control regulatory T-cell fate during inflammatory bowel disease (IBD) Bhalchandra Mirlekar, Suvankar Ghorai, M. B. Khetmalas, Mucosal Immunology	2015	20
Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3 Daniel Michaud, Bhalchandra Mirlekar, Steve Bischoff, Cytokine Tumor BiologyPancreatic CancerMedicineImmunologyPathology	2019	13

Page 1